SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Acquisition

28 Aug 2015 07:07

RNS Number : 4055X
Rentokil Initial PLC
28 August 2015
 



28 August 2015

Acquisition of Anderson Pest Solutions, USA

 

Rentokil Initial plc (FTSE: RTO, "the Company") announces the continued expansion of its pest control business with the acquisition of Chicago-based Anderson Pest Solutions ("Anderson"). Its annualised revenues for the 12 months prior to acquisition were $21m.

 

The acquisition is in line with the Company's strategy of continued acceleration of its pest control business and pursuing acquisition targets in higher growth markets. It also builds customer density, primarily in the Chicago metropolitan area.

Andy Ransom, Chief Executive of Rentokil Initial plc, said:

"We are delighted to join forces with Anderson Pest Solutions in the Chicago area. It is a well-established and highly respected business, and with long-term customer relationships.

"With an 80% commercial portfolio, areas of potential growth include introducing additional services such as Rentokil's bird control and bioremediation expertise to Anderson's customer base, but also the benefits that Anderson's particular expertise in eco-effective pest control will bring to us.

"North America is an important growth market for the Company and our pipeline of acquisitions in pest control remains strong as we expect to continue the acceleration in pest control and deliver the next phase in our plan for profitable growth."

 

Rentokil North America Strategy and Performance

· North America is a key strategic market in our Growth quadrant.

· As set out in the recent Rentokil Pest Control seminar, North America is the largest pest control market worldwide, with an estimated growth rate of ~3.5% in 2014.

· The Company's strategy for strong growth and rising margins in North America is to: increase scale in commercial pest control; drive profitability through route density building by the in-fill of areas with lower customer penetration; extend coverage and capability for national accounts; accelerate growth through M&A; and target local organic growth using the Rentokil model of targeted sales activity, upselling additional services, investment in brand building and high standards of customer satisfaction leading to customer retention.

· In the first six months of 2015, Rentokil Initial's North America region revenue grew 8.3%, with strong profit growth of 19.5% driven by acquisitions and leverage impact from higher revenues.

 

ENDS

 

Investor / Analyst enquiries:

Katharine Rycroft, Investor Relations, Rentokil Initial plc 07811 270 734

 

Media enquiries:

Malcolm Padley, Corporate Communications, Rentokil Initial plc 07788 978 199

 

About Rentokil Initial plc

Rentokil Initial is one of the largest business services companies in the world, operating in over 60 countries. The Company offers route-based services including Pest Control, Hygiene and Workwear through teams of local experts.

www.rentokil-initial.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUWUVRVWAWURR
Date   Source Headline
31st Mar 20211:16 pmRNSTotal Voting Rights
31st Mar 202110:33 amRNSAnnual Financial Report
30th Mar 20216:23 pmRNSDirector Declaration
24th Mar 20215:55 pmRNSDirector/PDMR Shareholding
12th Mar 20219:00 amRNSAdditional Listing
4th Mar 20217:05 amRNSDirectorate Change
4th Mar 20217:00 amRNSFinal Results
17th Feb 20215:45 pmRNSDirector Declaration
8th Jan 20217:00 amRNSQ4 2020 Acquisitions and Trading Update
27th Nov 20202:25 pmBUSEarly Repurchase(s)
27th Nov 20202:22 pmBUSEarly Repurchase(s)
24th Nov 20205:25 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSResult of Tender Offer for Notes due 2021
12th Nov 20209:02 amRNSTender Offer for Notes due 2021
22nd Oct 20207:00 amRNSQ3 Trading Update
8th Oct 20207:00 amRNSSuccessful EUR600m 8-year bond transaction priced
1st Oct 20209:00 amRNSBlock listing Interim Review
28th Aug 20203:40 pmRNSDirector/PDMR Shareholding
7th Aug 20205:24 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSInterim Results
6th Jul 20207:00 amRNSDirectorate Change
21st May 202011:00 amRNSDirector/PDMR Shareholding
13th May 20205:15 pmRNSResult of AGM
7th May 20204:45 pmRNSDirector/PDMR Shareholding
27th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
17th Apr 202011:59 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSQ1 Trading Update
14th Apr 20205:26 pmRNSHolding(s) in Company
9th Apr 20204:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20201:36 pmRNSDirector/PDMR Shareholding
1st Apr 20205:33 pmRNSConfirmation of Non-Executive Director Appointment
1st Apr 20209:24 amRNSBlock listing Interim Review
31st Mar 20202:18 pmRNSTotal Voting Rights
30th Mar 202012:37 pmRNSRedemption of 4.5% debenture stock
30th Mar 202012:24 pmRNSRedemption of 5% debenture stock
27th Mar 202011:00 amRNSHolding(s) in Company
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 202011:29 amRNSAnnual Financial Report
25th Mar 20207:00 amRNSTrading Update
19th Mar 202011:30 amRNSDirector Declaration
17th Mar 20201:15 pmRNSAdditional Listing
6th Mar 202012:00 pmRNSHolding(s) in Company
27th Feb 20207:05 amRNSDirectorate Change
27th Feb 20207:00 amRNSFinal Results
21st Feb 20204:00 pmRNSHolding(s) in Company
24th Dec 20191:10 pmRNSHolding(s) in Company
19th Dec 20192:40 pmRNSDirector/PDMR Shareholding
17th Dec 20195:10 pmRNSHolding(s) in Company
26th Nov 20196:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.